COMP <GO>
OMDA vs INNV // EV/EBITDA & P/E VALUATION
Omada Health Inc. (NASDAQ) VS. InnovAge Holding Corp. (NASDAQ) • 15-METRIC TALLY: OMDA 4
— INNV 6
■ METRIC PARITY
LAST: $19.65 (+2.45%) • MKT CAP: $1.20B
valuation
—
LAST: $9.24 (+1.54%) • MKT CAP: $1.26B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OMDA VS. INNV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OMDA | INNV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 65.70% | 18.00% | +47.70 | OMDA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -15.70% | -10.20% | -5.50 | INNV | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.41% | 2.11% | -0.70 | INNV | /fcf-yield <GO> |
| Operating Margin | -4.60% | -3.50% | -1.10 | INNV | /operating-margins <GO> |
| Net Profit Margin | -4.90% | -3.60% | -1.30 | INNV | /net-margins <GO> |
| Revenue Growth (YoY) | 53.20% | 11.80% | +41.40 | OMDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.93 | 4.47 | +4.46 | OMDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | OMDA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.6 | 45.7 | -2.16 | INNV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.20B | $1.26B | -$57.9M | INNV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OMDA REV | INNV REV | OMDA GROSS % | INNV GROSS % | OMDA FCF | INNV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $260.2M | $853.7M | 65.7% | 18.0% | $16.9M | $26.6M |
| FY 2024 | $169.8M | $763.9M | 60.6% | 17.3% | -$34.8M | -$44.8M |
| FY 2023 | $122.8M | $688.1M | — | — | -$49.7M | $20.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OMDA // BETA —
INNV // BETA —